CTIC insider filings
CTI BIOPHARMA CORP — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-06-28. Screen CTIC transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for CTIC between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — CTI BIOPHARMA CORP
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-06-28 | 4 | BVF PARTNERS L P/IL — Director, 10% owner BIOTECHNOLOGY VALUE FUND L P — Director, 10% owner BVF I GP LLC — Director, 10% owner BIOTECHNOLOGY VALUE FUND II LP — Director BVF II GP LLC — Director Biotechnology Value Trading Fund OS LP — Director BVF Partners OS Ltd. — Director BVF GP HOLDINGS LLC — Director, 10% owner BVF INC/IL — Director, 10% owner LAMPERT MARK N — Director, 10% owner | Code (U): 3,989,130 @ $9.10 · Code (U): 2,595,239 @ $9.10 · Code (U): 702,505 @ $9.10 · Code (U): 1,526,147 @ $9.10 · Code (U): 43,139 @ $9.10 · Code (U): 1,594 (derivative) · +12 more | EDGAR |
| 2023-06-26 | 4 | Fong James K — EVP & Chief Commercial Officer | Code (U): 3,565 @ $9.10 · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 8,250 (derivative) · Disposition to issuer (D): 58,750 (derivative) · Disposition to issuer (D): 23,340 (derivative) · Disposition to issuer (D): 188,000 (derivative) · +4 more | EDGAR |
| 2023-06-26 | 4 | Parks Diane L. — Director | Disposition to issuer (D): 120,000 (derivative) · Disposition to issuer (D): 80,000 (derivative) · Disposition to issuer (D): 80,000 (derivative) | EDGAR |
| 2023-06-26 | 4 | Tuckson Reed Vaughn — Director | Code (U): 48,639 @ $9.10 · Disposition to issuer (D): 50,000 (derivative) · Disposition to issuer (D): 60,000 (derivative) · Disposition to issuer (D): 120,000 (derivative) · Disposition to issuer (D): 126,000 (derivative) · Disposition to issuer (D): 80,000 (derivative) · +2 more | EDGAR |
| 2023-06-26 | 4 | Metzger Michael A — Director | Disposition to issuer (D): 50,000 (derivative) · Disposition to issuer (D): 60,000 (derivative) · Disposition to issuer (D): 63,000 (derivative) · Disposition to issuer (D): 80,000 (derivative) · Disposition to issuer (D): 80,000 (derivative) · Disposition to issuer (D): 80,000 (derivative) | EDGAR |
| 2023-06-26 | 4 | PERRY MATTHEW D — Director | Code (U): 43,139 @ $9.10 · Disposition to issuer (D): 50,000 (derivative) · Disposition to issuer (D): 60,000 (derivative) · Disposition to issuer (D): 120,000 (derivative) · Disposition to issuer (D): 80,000 (derivative) · Disposition to issuer (D): 80,000 (derivative) · +1 more | EDGAR |
| 2023-06-26 | 4 | Parkinson David Ross — Director | Disposition to issuer (D): 50,000 (derivative) · Disposition to issuer (D): 60,000 (derivative) · Disposition to issuer (D): 120,000 (derivative) · Disposition to issuer (D): 126,000 (derivative) · Disposition to issuer (D): 80,000 (derivative) · Disposition to issuer (D): 80,000 (derivative) · +1 more | EDGAR |
| 2023-06-26 | 4 | Fischer Laurent — Director | Disposition to issuer (D): 50,000 (derivative) · Disposition to issuer (D): 60,000 (derivative) · Disposition to issuer (D): 120,000 (derivative) · Disposition to issuer (D): 126,000 (derivative) · Disposition to issuer (D): 80,000 (derivative) · Disposition to issuer (D): 80,000 (derivative) · +1 more | EDGAR |
| 2023-06-26 | 4 | Craig Adam R — President and CEO, Director | Code (U): 31,470 @ $9.10 · Disposition to issuer (D): 1,200,000 (derivative) · Disposition to issuer (D): 450,000 (derivative) · Disposition to issuer (D): 475,000 (derivative) · Disposition to issuer (D): 600,000 (derivative) · Disposition to issuer (D): 470,054 (derivative) · +4 more | EDGAR |
| 2023-06-26 | 4 | KIRSKE DAVID — EVP, Chief Financial Officer | Code (U): 17,547 @ $9.10 · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 315,000 (derivative) · Disposition to issuer (D): 83,396 (derivative) · Disposition to issuer (D): 270,216 (derivative) · Disposition to issuer (D): 340,000 (derivative) · +3 more | EDGAR |
| 2023-04-07 | 4 | Parks Diane L. — Director | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2023-04-07 | 4 | Tuckson Reed Vaughn — Director | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2023-04-07 | 4 | Metzger Michael A — Director | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2023-04-07 | 4 | PERRY MATTHEW D — Director | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2023-04-07 | 4 | Parkinson David Ross — Director | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2023-04-07 | 4 | Fischer Laurent — Director | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2023-04-07 | 4 | BVF PARTNERS L P/IL — Director, 10% owner BIOTECHNOLOGY VALUE FUND L P — Director, 10% owner BVF I GP LLC — Director, 10% owner BIOTECHNOLOGY VALUE FUND II LP — Director BVF II GP LLC — Director Biotechnology Value Trading Fund OS LP — Director BVF Partners OS Ltd. — Director BVF GP HOLDINGS LLC — Director, 10% owner BVF INC/IL — Director, 10% owner LAMPERT MARK N — Director, 10% owner | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2023-03-16 | 4 | Fong James K — EVP & Chief Commercial Officer | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2023-03-16 | 4 | Craig Adam R — President and CEO, Director | Grant/award (A): 900,000 (derivative) @ $0 | EDGAR |
| 2023-03-16 | 4 | KIRSKE DAVID — EVP, Chief Financial Officer | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2023-01-26 | 4 | Fong James K — EVP & Chief Commercial Officer | Option exercise (M): 100,000 @ $0.95 · Sale (S): 100,000 @ $6 · Grant/award (A): 288,000 (derivative) @ $0 · Option exercise (M): 100,000 (derivative) @ $0 | EDGAR |
| 2023-01-26 | 4 | Craig Adam R — President and CEO, Director | Option exercise (M): 83,200 @ $0.84 · Sale (S): 83,200 @ $6 · Option exercise (M): 2,117 @ $0.84 · Sale (S): 2,117 @ $6.01 · Option exercise (M): 83,200 (derivative) @ $0 · Option exercise (M): 2,117 (derivative) @ $0 | EDGAR |
| 2023-01-03 | 4 | Craig Adam R — President and CEO, Director | Option exercise (M): 13,800 @ $0.84 · Sale (S): 13,800 @ $6 · Grant/award (A): 1,579 @ $5.11 · Option exercise (M): 12,000 @ $0.84 · Sale (S): 12,000 @ $6 · Option exercise (M): 700 @ $0.84 · +10 more | EDGAR |
| 2023-01-03 | 4 | KIRSKE DAVID — EVP, Chief Financial Officer | Option exercise (M): 13,174 @ $0.95 · Sale (S): 13,174 @ $6 · Grant/award (A): 214 @ $5.11 · Option exercise (M): 12,000 @ $0.95 · Sale (S): 12,000 @ $6 · Option exercise (M): 800 @ $0.95 · +10 more | EDGAR |
| 2022-11-14 | 4 | Craig Adam R — President and CEO, Director | Option exercise (M): 53,996 @ $0.84 · Sale (S): 46,100 @ $6 · Sale (S): 7,596 @ $6.01 · Sale (S): 300 @ $6.01 · Option exercise (M): 188,304 @ $0.84 · Sale (S): 136,408 @ $6 · +8 more | EDGAR |
| 2022-11-10 | 4 | Metzger Michael A — Director | Option exercise (M): 28,500 @ $0.84 · Option exercise (M): 63,000 @ $1 · Sale (S): 50,058 @ $5.53 · Sale (S): 36,942 @ $5.65 · Sale (S): 4,500 @ $5.70 · Option exercise (M): 28,500 (derivative) @ $0 · +1 more | EDGAR |
| 2022-10-06 | 4 | KIRSKE DAVID — EVP, Chief Financial Officer | Option exercise (M): 1,400 @ $0.95 · Sale (S): 1,400 @ $6.25 · Option exercise (M): 100 @ $0.95 · Sale (S): 100 @ $6.26 · Option exercise (M): 609 @ $0.95 · Sale (S): 609 @ $6.27 · +3 more | EDGAR |
| 2022-10-03 | 4 | KIRSKE DAVID — EVP, Chief Financial Officer | Option exercise (M): 800 @ $0.95 · Sale (S): 800 @ $6 · Option exercise (M): 100 @ $0.95 · Sale (S): 100 @ $6.01 · Option exercise (M): 139,841 @ $0.95 · Sale (S): 139,841 @ $6.05 · +6 more | EDGAR |
| 2022-09-20 | 4 | KIRSKE DAVID — EVP, Chief Financial Officer | Grant/award (A): 9,516 @ $2.12 · Option exercise (M): 22,592 @ $0.95 · Sale (S): 22,592 @ $6.02 · Option exercise (M): 22,592 (derivative) @ $0 | EDGAR |
| 2022-09-14 | 4 | Craig Adam R — President and CEO, Director | Option exercise (M): 242,300 @ $0.84 · Sale (S): 242,300 @ $6.43 · Option exercise (M): 242,300 (derivative) @ $0 | EDGAR |
| 2022-08-16 | 4 | Craig Adam R — President and CEO, Director | Purchase (P): 5,000 @ $5.50 | EDGAR |
| 2022-08-11 | 4 | BVF PARTNERS L P/IL — Director, 10% owner BIOTECHNOLOGY VALUE FUND L P — Director, 10% owner BVF I GP LLC — Director, 10% owner BIOTECHNOLOGY VALUE FUND II LP — Director BVF II GP LLC — Director Biotechnology Value Trading Fund OS LP — Director BVF Partners OS Ltd. — Director BVF GP HOLDINGS LLC — Director, 10% owner BVF INC/IL — Director, 10% owner LAMPERT MARK N — Director, 10% owner | Sale (S): 3,850,803 @ $6.12 · Conversion (C): 3,754,000 · Sale (S): 2,890,723 @ $6.12 · Conversion (C): 2,426,666 · Sale (S): 469,040 @ $6.12 · Conversion (C): 682,666 · +6 more | EDGAR |
| 2022-07-11 | 4 | Metzger Michael A — Director | Sale (S): 9,000 @ $6.50 · Sale (S): 5,900 @ $6.51 · Sale (S): 3,321 @ $6.52 · Sale (S): 400 @ $6.53 · Sale (S): 400 @ $6.54 · Sale (S): 1,100 @ $6.55 | EDGAR |
| 2022-07-07 | 4 | Metzger Michael A — Director | Option exercise (M): 91,500 @ $0.84 · Sale (S): 8,700 @ $5.98 · Sale (S): 51,963 @ $6.05 · Sale (S): 27,506 @ $6.14 · Sale (S): 3,331 @ $6.23 · Option exercise (M): 91,500 (derivative) @ $0 | EDGAR |
| 2022-07-06 | 4 | Craig Adam R — President and CEO, Director | Grant/award (A): 6,183 @ $2.12 · Option exercise (M): 27,000 @ $0.84 · Sale (S): 27,000 @ $6 · Option exercise (M): 27,000 @ $0.84 · Sale (S): 27,000 @ $6 · Option exercise (M): 18,223 @ $0.84 · +4 more | EDGAR |
| 2022-06-17 | 4 | KIRSKE DAVID — EVP, Chief Financial Officer | Option exercise (M): 10,000 @ $1 · Sale (S): 10,000 @ $6 · Option exercise (M): 50,000 @ $3.30 · Sale (S): 50,000 @ $6.25 · Option exercise (M): 10,000 (derivative) @ $0 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2022-06-16 | 4 | KIRSKE DAVID — EVP, Chief Financial Officer | Option exercise (M): 10,000 @ $0.95 · Sale (S): 10,000 @ $5.50 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2022-06-03 | 4 | Craig Adam R — President and CEO, Director | Option exercise (M): 27,000 @ $0.84 · Sale (S): 27,000 @ $6 · Option exercise (M): 27,000 @ $0.84 · Sale (S): 27,000 @ $6 · Option exercise (M): 18,223 @ $0.84 · Sale (S): 18,223 @ $6.01 · +3 more | EDGAR |
| 2022-06-03 | 4/A | Craig Adam R — President and CEO, Director | Option exercise (M): 27,000 (derivative) @ $0 · Option exercise (M): 27,000 (derivative) @ $0 · Option exercise (M): 18,223 (derivative) @ $0 | EDGAR |
| 2022-03-11 | 4 | Parks Diane L. — Director | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2022-03-11 | 4 | Tuckson Reed Vaughn — Director | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2022-03-11 | 4 | Metzger Michael A — Director | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2022-03-11 | 4 | SEELEY BRUCE J. — EVP, Chief Operating Officer | Grant/award (A): 3,164 @ $2.12 · Grant/award (A): 3,241 @ $2.11 · Grant/award (A): 280,000 (derivative) @ $0 | EDGAR |
| 2022-03-11 | 4 | PERRY MATTHEW D — Director | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2022-03-11 | 4 | Parkinson David Ross — Director | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2022-03-11 | 4 | Fischer Laurent — Director | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2022-03-11 | 4 | Craig Adam R — President and CEO, Director | Grant/award (A): 3,178 @ $2.11 · Grant/award (A): 1,115,000 (derivative) @ $0 | EDGAR |
| 2022-03-11 | 4 | KIRSKE DAVID — EVP, Chief Financial Officer | Grant/award (A): 1,782 @ $2.12 · Grant/award (A): 1,817 @ $2.11 · Grant/award (A): 280,000 (derivative) @ $0 | EDGAR |
| 2022-03-11 | 4 | BVF PARTNERS L P/IL — Director, 10% owner BIOTECHNOLOGY VALUE FUND L P — 10% owner BVF I GP LLC — 10% owner BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC — 10% owner BVF INC/IL — 10% owner LAMPERT MARK N — 10% owner | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2021-12-02 | 4 | Craig Adam R — President and CEO, Director | Grant/award (A): 5,000 @ $2.12 · Purchase (P): 1,322 @ $1.52 · Purchase (P): 2,178 @ $1.52 | EDGAR |
Recent 8-K events — CTI BIOPHARMA CORP
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2023-06-26 | 8-K | 1.02 — Termination of a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 2.04 — Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-05-30 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-05-10 | 8-K | 1.01 — Entry into a Material Definitive Agreement 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-03-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-11-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-10-13 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2022-09-28 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-08-15 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-08-08 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-06-03 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CTIC returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs